Study of the prothrombin gene 20201 GA variant in FV:Q506 carriers in relationship to the presence or absence of juvenile venous thromboembolism.

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Arteriosclerosis, Thrombosis and Vascular Biology

• Publication date

  1999-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1161/01.ATV.19.2.276PMID 9974407
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The A20210 allele of the prothrombin gene is frequently associated with the factor V Arg 506 to Gln mutation but not with protein S deficiency in thrombophilic families.

  1998cited by this paper
• High Prevalence of Factor V R506Q Mutation in German Thrombophilic and Normal Population

  1998cited by this paper
• Prevalence of the prothrombin gene G20210A variant in an UK anticoagulant clinic population

  1997cited by this paper
• A common prothrombin variant (20210 G to A) increases the risk of myocardial infarction in young women.

  1997cited by this paper
• Risk of venous thromboembolism associated with a G to A transition at position 20210 in the 3′‐untranslated region of the prothrombin gene

  1997cited by this paper
• The A20210 allele of the prothrombin gene is not frequently associated with the factor V Arg 506 to Gln mutation in thrombophilic families.

  1997cited by this paper
• A prothrombin gene mutation is significantly associated with venous thrombosis.

  1997cited by this paper
• The prothrombin gene G20210A variant: prevalence in a U.K. anticoagulant clinic population

  1997cited by this paper
• The heterozygous 20210 G/A prothrombin genotype is associated with early venous thrombosis in inherited thrombophilias and is not increased in frequency in artery disease.

  1997cited by this paper
• The 20210 A Allele of the Prothrombin Gene Is a Common Risk Factor among Swedish Outpatients with Verified Deep Venous Thrombosis

  1997cited by this paper
• Inherited Thrombophilia*: Part 2

  1996cited by this paper
• Inherited Thrombophilia: Part 1

  1996cited by this paper
• A common genetic variation in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis.

  1996cited by this paper
• Resistance to activated protein C (APCR) in children with venous or arterial thromboembolism

  1996cited by this paper
• Inherited thrombophilia: pathogenesis, clinical syndromes, and management.

  1996cited by this paper
• Factor V Leiden (FV R506Q) in Families with Inherited Antithrombin Deficiency

  1996cited by this paper
• Venous thromboembolism associated with double heterozygosity for R506Q mutation of factor V and for T298M mutation of protein C in a large family of a previously described homozygous protein C-deficient newborn with massive thrombosis.

  1996cited by this paper
• World distribution of factor V Leiden.

  1996cited by this paper
• Molecular basis of protein S deficiency in three families also showing independent inheritance of factor V leiden.

  1996cited by this paper
• High risk of thrombosis in patients homozygous for factor V Leiden (activated protein C resistance)

  1995cited by this paper
• Incidence of activated protein C resistance caused by the ARG 506 GLN mutation in factor V in 113 unrelated symptomatic protein C-deficient patients. The French Network on the behalf of INSERM.

  1995cited by this paper
• Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men.

  1995cited by this paper
• World distribution of factor V Leiden.

  1995cited by this paper
• An allosteric switch controls the procoagulant and anticoagulant activities of thrombin.

  1995cited by this paper
• Resistance to activated protein C as an additional genetic risk factor in hereditary deficiency of protein S.

  1995cited by this paper
• Population differences in the frequency of the factor V Leiden variant among people with clinically symptomatic protein C deficiency.

  1995cited by this paper
• Factor V Leiden: An Additional Risk Factor for Thrombosis in Protein S Deficient Families?

  1995cited by this paper
• Activated protein C resistance caused by Arg506Gln mutation in factor Va.

  1994cited by this paper
• Resistance to activated protein C as a basis for venous thrombosis.

  1994cited by this paper
• Activated protein C resistance as an additional risk factor for thrombosis in protein C-deficient families.

  1994cited by this paper
• Mutation in blood coagulation factor V associated with resistance to activated protein C

  1994cited by this paper
• Anticoagulant protein C pathway defective in majority of thrombophilic patients.

  1993cited by this paper
• Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C.

  1993cited by this paper
• Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study.

  1993cited by this paper
• Inherited predisposition to thrombosis.

  1993cited by this paper
• Thrombin, a Link between Coagulation Activation and Fibrinolysis a

  1992cited by this paper
• Nucleotide sequence of the gene for human prothrombin.

  1987cited by this paper
• Haemostasis and thrombosis

  1981cited by this paper

• Neurologic Manifestations of Hematologic Disorders

  2021cites this paper
• Thrombophilia

  2021cites this paper
• 17 Thrombophilia in the young Hämostaseologie 1 – 2 / 2008 Thrombotic events in paediatric patients Locations

  2017cites this paper
• Prothrombin polymorphism A19911G, factor V HR2 haplotype A4070G, and plasminogen activator-inhibitor-1 polymorphism 4G/5G and the risk of retinal vein occlusion

  2017cites this paper
• Frequency and association of 1691 (G>A) FVL, 20210 (G>A) PT and 677 (C>T) MTHFR with deep vein thrombosis in the population of Bosnia and Herzegovina

  2016cites this paper
• Hematological Risk Factors for Coronary Heart Disease

  2016cites this paper
• Venous thromboembolism in neonates and children.

  2012cites this paper
• Frequency of Triple Mutations Involving Factor V, Prothrombin, and Methylenetetrahydrofolate Reductase Genes Among Patients Referred for Molecular Thrombophilia Workup in a Tertiary Care Center in Lebanon

  2012cites this paper
• Thrombophilia testing in neonates and infants with thrombosis.

  2011cites this paper
• Massive Pulmonary Embolism Associated With Factor V Leiden, Prothrombin, and Methylenetetrahydrofolate Reductase Gene Mutations in a Young Patient on Oral Contraceptive Pills: A Case Report

  2010cites this paper
• Multiple gene interaction and modulation of hemostatic balance

  2009cites this paper
• Ocular Vascular Thrombotic Events: A Diagnostic Window to Familial Thrombophilia (Compound Factor V Leiden and Prothrombin Gene Heterozygosity) and Thrombosis

  2009cites this paper
• [Myocardial infarction and pulmonary embolism in a 45 year-old woman with the prothrombin 20210A mutation--a case report].

  2009influential citation
• Coagulation disorders and the risk of retinal vein occlusion

  2009cites this paper
• Thrombophilia in the young.

  2008cites this paper
• Impact of Inherited Thrombophilia on Venous Thromboembolism in Children: A Systematic Review and Meta-Analysis of Observational Studies

  2008cites this paper
• Chapter 13 – Neurological Manifestations of Hematological Disorders

  2008cites this paper
• Genetic prothrombotic mutations are common in neonates but are not associated with umbilical catheter-associated thrombosis

  2007cites this paper
• Impact of Thrombophilic Genetic Factors on Pulmonary Embolism: Early Onset and Recurrent Incidences

  2007cites this paper
• MASSIVE PULMONARY EMBOLISM: THE PREDISPOSING AND COMPLICATING FACTORS, ITS CURRENT DIAGNOSTIC APPROACHES AND CRITICAL IMPORTANCE OF EARLY DIAGNOSTIC PHYSICAL EXAM

  2006cites this paper
• The Role of Genetics in the Risk of Thromboembolism: Prothrombin 20210A and Oral Contraceptive Therapy

  2004cites this paper
• Impact of environmental and hereditary risk factors on the clinical manifestation of thrombophilia in homozygous carriers of factor V:G1691A

  2004cites this paper
• First thromboembolic Onset in Children carrying either the heterozygeous Factor V G1691A Mutation or the Prothrombin G20210A Variant

  2003cites this paper
• Coexistence of Two Prothrombotic Mutations, Factor V 1691 G-A and Prothrombin 20210 G-A, and the Risk of Thrombosis in Turkish Population.

  2003cites this paper
• Activated protein C resistance (FV(Leiden)) and thrombosis: factor V mutations causing hypercoagulable states.

  2003cites this paper
• Role of acquired and inherited Prothrombotic Risk Factors in Pediatric Cerebral Venous Thrombosis — Preliminary Results of a Multicenter Case-Control Study

  2002cites this paper
• The use of coagulation activation markers (soluble fibrin polymer, TpPTM, prothrombin fragment 1.2, thrombin–antithrombin, and D-dimer) in the assessment of hypercoagulability in patients with inherited and acquired prothrombotic disorders

  2002cites this paper
• Factor V and Thrombotic Disease: Description of a Janus-Faced Protein

  2002cites this paper
• Hematological Risk Factors for Coronary Heart Disease

  2002cites this paper
• Pathogenesis of venous thromboembolism.

  2002cites this paper
• Risk factors for thromboembolism in teens: when should I test?

  2002cites this paper
• Genetic susceptibility to venous thrombosis.

  2001cites this paper
• Mechanisms of Thrombosis in Inherited Thrombophilia

  2001cites this paper
• Genetic Approach to Thrombophilia

  2001cites this paper
• A family history can display a synergistic effect of atherogenic and prothrombotic risk in pregnancy

  2001cites this paper
• Severe Neonatal Thrombosis in a Patient with Factor V Q:506 Mutation and the G20210A Prothrombin Mutation

  2001cites this paper
• G ENETIC S USCEPTIBILITY TO V ENOUS T HROMBOSIS

  2001cites this paper
• Hereditary Thrombophilic Risk Profiles in Children with Spontaneous Venous Thromboembolism

  2001cites this paper
• Combined factor V Leiden and prothrombin genotyping in patients presenting with thromboembolic episodes.

  2001cites this paper
• Prevalence and association of the factor V Leiden and prothrombin G20210A in healthy subjects and patients with venous thromboembolism.

  2001cites this paper
• Risk of recurrent venous thrombosis in children with combined prothrombotic risk factors.

  2001cites this paper
• Prothrombotic risk factors in patients with thrombangitis obliterans.

  2000cites this paper
• Abdominal venous thrombosis in neonates and infants: role of prothrombotic risk factors - a multicentre case-control study. For the Childhood Thrombophilia Study Group.

  2000cites this paper
• Clinical and laboratory expression of associated thrombophilic conditions (homozygous/heterozygous factor V Leiden mutation and heterozygous prothrombin variant 20210A) in an Italian family

  2000cites this paper
• Abdominal venous thrombosis in neonates and infants: role of prothrombotic risk factors – a multicentre case–control study

  2000cites this paper
• Anticoagulant prophylaxis and therapy in patients with cancer.

  2000cites this paper
• Prothrombotic risk factors in children with spontaneous venous thrombosis and their asymptomatic parents: a family study.

  2000cites this paper
• Aspects of the Clinical Management of Hereditary Thrombophilia: A Personal Perspective

  2000cites this paper
• Variantes genéticas como fatores de risco para trombose venosa

  2000cites this paper
• Inhibition of activated protein C anticoagulant activity by prothrombin.

  1999cites this paper
• Double carriers of the factor V Leiden and prothrombin (FIIG20210A) mutations: a description of four cases.

  1999cites this paper
• A combination of prednisone, high-dose intravenous immunoglobulin and desmopressin in the treatment of acquired hemophilia A with high-titer inhibitor.

  1999cites this paper
• The 677T genotype of the common MTHFR thermolabile variant and fasting homocysteine in childhood venous thrombosis

  1999cites this paper
• Prothrombin G20210A gene mutation and further prothrombotic risk factors in childhood thrombophilia.

  1999cites this paper
• Genetic Approach to Thrombophilia Rogier

  year unknowncites this paper